Skip to content

Study on the effect of Life Enhancer probiotic combined with protein supplements on sarcopenia in older adults

Study on the effect of Life Enhancer probiotic combined with protein supplements on sarcopenia in older adults

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085432
Enrollment
Unknown
Registered
2024-06-07
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Nutrition Education + Probiotics and protein group: Nutrition Education + 40g protein pre day, and life enhancer probiotics including bacillus coagulans (5*10^8CFU/g) and clostridium butylicum (5*10^7
Nutrition Education + Probiotics placebo and protein group:Nutrition Education + 40g protein pre day and Probiotics placebo tablets twice a day.
Nutrition Education + Probiotics group : Nutrition Education + Life enhancer probiotics including bacillus coagulans (5*10^8CFU/g) and clostridium butylicum (5*10^7 CFU/g), twice a day.
Nutrition Education + Probiotics placebo group:Nutrition Education + Probiotics placebo tablets twice a day.

Sponsors

Shanghai fourth people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) =60 years old, gender is not limited; (2) According to the Asian Working Group for Sarcopenia (AWGS), patients should meet the diagnostic standards of sarcopenia; (3) Patients should have the ability to oral feeding and tolerate nutritional supplements; (4) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients who can't tolerate nutritional supplements; (2) Patients who have diseases that seriously affect the digestion and absorption of nutritional supplements; (3) Patients who have severe kidney or liver failure, or malignancies that are receiving chemotherapy or with edema, have mental disorders before trail. (4) Patients have dysfunction of lower limb joint, which could affect walking independently; (5) Patients who have been implanted metal or electronic devices into the body that affect the examination; (6) Patients who are using medication interfering with the nutritional intervention; (7) Patients who are using drugs that may affect the trail ( such as hormones, anti-tumor drugs, sedation or other muscle relaxants); (8) Those who have taken antibiotics or probiotics within one month; (9) Other reasons that were not suitable for clinical trials; (10) Patients who disagree to sign informed consent.

Design outcomes

Primary

MeasureTime frame
indexes of skeletal muscle mass;

Secondary

MeasureTime frame
gut microbiota;nutritional indices;inflammatory index;quality of life assessment;

Countries

China

Contacts

Public ContactWang Ying

Shanghai fourth people's hospital

18916484569@163.com+86 189 1648 4569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026